Sekula, Peggy
Peggy Sekula researcher
VIAF ID: 258604659 ( Personal )
Permalink: http://viaf.org/viaf/258604659
Preferred Forms
- 100 0 _ ‡a Peggy Sekula ‡c researcher
- 100 1 _ ‡a Sekula, Peggy
4xx's: Alternate Name Forms (2)
5xx's: Related Names (3)
Works
Title | Sources |
---|---|
Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example | |
Clinical decision making in small non-functioning VHL-related incidentalomas | |
Control procedures and estimators of the false discovery rate and their application in low-dimensional settings: an empirical investigation | |
Design choices for observational studies of the effect of exposure on disease incidence | |
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles | |
From discovery to translation: characterization of the novel kidney function markers C-mannosyltryptophan and pseudouridine | |
Genetic studies of paired metabolomes reveal enzymatic and transport processes at the interface of plasma and urine | |
Genetics of osteopontin in patients with chronic kidney disease: the German chronic kidney disease study | |
Genome-wide studies reveal factors associated with circulating uromodulin and its relations with complex diseases | |
Growth characteristics and therapeutic decision markers in von Hippel Lindau disease patients with renal cell carcinoma | |
Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations | |
Methods for evaluating medical tests and biomarkers | |
pgainsim: an R-package to assess the mode of inheritance for quantitative trait loci in GWAS | |
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease | |
Rare genetic variants affecting urine metabolite levels link population variation to inborn errors of metabolism | |
relationship between blood metabolites of the tryptophan pathway and kidney function: a bidirectional Mendelian randomization analysis | |
Statistische Modellierung zur Risikobeurteilung in der Pharmakoepidemiologie: die case-crossover-Methode | |
Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease | |
Using transgenic Drosophila model to study the mechanism of APOL1-associated cytotoxicity |